Influence of severity of myocardial injury on distribution of macromolecules: Extravascular versus intravascular gadolinium-based magnetic resonance contrast agents

Journal of the American College of Cardiology

Volumn 30, Issue 4, 1997, Pages 1086-1094

  Schwitter, Juerg ^a   Saeed, Maythem ^a   Wendland, Michael F ^a   Derugin, Nikita ^a   Canet, Emmanuelle ^a   Brasch, Robert C ^a   Higgins, Charles B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADODIAMIDE; GADOLINIUM PENTETATE ALBUMIN; SODIUM CHLORIDE; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE INJURY; HEART MUSCLE REPERFUSION; MACROMOLECULE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; SIGNAL DETECTION; TISSUE DISTRIBUTION;

ALBUMINS; ANALYSIS OF VARIANCE; ANIMALS; CONTRAST MEDIA; GADOLINIUM DTPA; MAGNETIC RESONANCE IMAGING; MOLECULAR WEIGHT; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; RATS; RATS, SPRAGUE-DAWLEY; SEVERITY OF ILLNESS INDEX; TISSUE DISTRIBUTION;

EID: 0030866912     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00245-3     Document Type: Article

References (47)

1. Kloner RA, Rude RE, Carlson N, Maroko PR, DeBoer LW, Braunwald E. Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: which comes first? Circulation 1980;62:945-52.
2. Kloner RA, Fishbein MC, Hare CM, Maroko PR. Early ischemic ultrastructural and histochemical alterations in the myocardium of the rat following coronary artery occlusion. Exp Mol Pathol 1979;30:129-43.
3. Hale SL, Kloner RA. Effect of early coronary artery reperfusion on infarct development in a model of low collateral flow. Cardiovasc Res 1987;21:668-73.
4. Dauber IM, VanBenthuysen KM, McMurtry IF, et al. Functional coronary microvascular injury evident as increased permeability due to brief ischemia and reperfusion. Cire Res 1990;66:986-98.
5. West PN, Connors JP, Clark RE, et al. Compromised microvascular integrity in ischemic myocardium. Lab Invest 1978;38:677-84.
6. Pereira RS, Prato FS, Wisenberg G, Sykes J. The determination of myocardial viability using Gd-DTPA in a canine model of acute myocardial ischemia and reperfusion. Magn Reson Med 1996;36:684-93.
7. Saeed M, Wendland MF, Takehara Y, Masui T, Higgins CB. Reperfusion and irreversible myocardial injury: identification with a nonionic MR imaging contrast medium. Radiology 1992;182:675-83.
8. Lauerma K, Saeed M, Wendland MF, Derugin N, Yu KK, Higgins CB. The use of contrast-enhanced magnetic resonance imaging to define ischemic injury after reperfusion: comparison in normal and hypertrophied hearts. Invest Radiol 1994;29:527-35.
9. Saeed M, Wendland MF, Masui T, Higgins CB. Reperfused myocardial infarctions on T1- and susceptibility-enhanced MRI: evidence for loss of compartmentalization of contrast media. Magn Reson Med 1994;31:31-9.
10. Wolfe CL, Moseley ME, Wikstrom MG, et al. Assessment of myocardial salvage after ischemia and reperfusion using magnetic resonance imaging and spectroscopy. Circulation 1989;80:969-82.
11. de Roos A, van Rossum A, van der Wall E, et al. Reperfused and nonreperfused myocardial infarction: diagnostic potential of Gd-DTPA-enhanced MR imaging. Radiology 1989;172:717-20.
12. de Roos A, Matheijssen NA, Doornbos J, van Dijkman P, van Voorthuisen A, van der Wall E. Myocardial infarct size after reperfusion therapy: assessment with Gd-DTPA-enhanced MR imaging. Radiology 1990;176: 517-21.
13. Kim RJ, Chen EL, Lima JA, Judd RM. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation 1996;94: 3318-26.
14. Judd RM, Lugo OC, Arai M, et al. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation 1995;92:1902-10.
15. Lima JA, Judd RM, Bazille A, Schulman SP, Atalar E, Zerhouni EA. Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. Circulation 1995;92:1117-25.
16. Lim TH, Lee DH, Kim YH, et al. Occlusive and reperfused myocardial infarction: detection by using MR imaging with gadolinium polylysine enhancement. Radiology 1993;189:765-8.
17. Lim TH, Lee JH, Gong G, Park SJ, Lee I. Significance of magnetic resonance signal enhancement in evaluation of myocardial infarction in cats. Invest Radiol 1995;30:306-14.
18. Schaefer S, Malloy CR, Katz J, et al. Gadolinium-DTPA-enhanced nuclear magnetic resonance imaging of reperfused myocardium: identification of the myocardial bed at risk. J Am Coll Cardiol 1988;12:1064-72.
19. Weinmann HJ, Brasch RC, Press WR, Wesbey GE. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. AJR 1984;142: 619-24.
20. Wendland MF, Saeed M, Lauerma K, et al. Alterations in T1 of normal and reperfused infarcted myocardium after Gd-BOPTA versus GD-DTPA on inversion recovery EPI. Magn Reson Med 1997;37:448-56.
21. Saeed M, Wendland MF, Yu KK, et al. Identification of myocardial reperfusion with echo planar magnetic resonance imaging: discrimination between occlusive and reperfused infarctions. Circulation 1994;90:1492-501.
22. Saeed M, van Dijke CF, Mann J, Wendland MF, Rosenau W, Brasch RC. Microscopic and MR detection of gadolinium-albumin-DTPA-biotin distribution in reperfused myocardial infarction [abstract]. Proc Soc Magn Res 1995;2:1141.
23. Simor T, Chu WJ, Johnson L, et al. In vivo MRI visualization of acute myocardial ischemia and reperfusion in ferrets by the persistent action of the contrast agent Gd (BME-DTTA). Circulation 1995;92:3549-59.
24. Hale SL, Kloner RA. Left ventricular topographic alterations in the completely healed rat infarct caused by early and late coronary artery reperfusion. Am Heart J 1988;116:1508-13.
25. Rocklage SM, Watson AD. Chelates of gadolinium and dysprosium as contrast agents for MR imaging. J Magn Reson Imaging 1993;3:167-78.
26. Ogan MD, Schmiedl U, Moseley ME, Grodd W, Paajanen H, Brasch RC. Albumin labeled with Gd-DTPA: an intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization [published erratum appears in Invest Radiol 1988;23:961]. Invest Radiol 1987;22:665-71.
27. Oh BH, Ono S, Rockman HA, Ross JJ. Myocardial hypertrophy in the ischemic zone induced by exercise in rats after coronary reperfusion. Circulation 1993;87:598-607.
28. Horneffer PJ, Healy B, Gott VL, Gardner TJ. The rapid evolution of a myocardial infarction in an end-artery coronary preparation. Circulation 1987;39 Suppl V:V-39-42.
29. Lotan CS, Bouchard A, Cranney GB, Bishop SP, Pohost GM. Assessment of postreperfusion myocardial hemorrhage using proton NMR imaging at 1.5 T. Circulation 1992;86:1018-25.
30. Vivaldi MT, Kloner RA, Schoen FJ. Triphenyltetrazolium staining of irreversible ischemic injury following coronary artery occlusion in rats. Am J Pathol 1985;121:522-30.
31. Fishbein MC, Meerbaum S, Rit J, et al. Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J 1981;101:593-600.
32. Geschwind J-FH, Wendland MF, Saeed M, Lauerma K, Derugin N, Higgins CH. Identification of myocardial cell death in reperfused myocardial injury using dual mechanisms of contrast-enhanced magnetic resonance imaging. Acad Radiol 1994;1:319-25.
33. Willerson JT, Scales F, Mukherjee A, et al. Abnormal myocardial fluid retention as an early manifestation of ischemic injury. Am J Pathol 1977;87:159-88.
34. Ganote CE, Seabra GR, Nayler WG, Jennings RB. Irreversible myocardial injury in anoxic perfused rat hearts. Am J Pathol 1975;80:419-50.
35. Farb A, Kolodgie FD, Jenkins M, Virmani R. Myocardial infarct extension during reperfusion after coronary artery occlusion: pathologic evidence. J Am Coll Cardiol 1993;21:1245-53.
36. Sunnergren KP, Rovetto MJ. Myocyte and endothelial injury with ischemia reperfusion in isolated rat hearts. Am J Physiol 1987;252:H1211-7.
37. Granger HJ, Glen AL, Barnes GE, Lewis RE. Dynamics and control of transmicrovascular fluid exchange. In: Staub NC, Tayler AET, editors. Edema. New York: Raven Press, 1984:189-227.
38. Bassingthwaighte JB, Wang CY, Chan IS. Blood-tissue exchange via transport and transformation by capillary endothelial cells. Circ Res 1989;65:997-1020.
39. Sunnergren KP, Rovetto MJ. Microvascular permeability characteristics of the isolated perfused ischemic rat heart. J Mol Cell Cardiol 1980;12: 1011-31.
40. Renkin EM, Joyner WL, Sloop CH, Watson PD. Influence of venous pressure on plasma-lymph transport in the dog's paw: convective and dissipative mechanisms. Microvasc Res 1977;14:191-204.
41. Harris TR, L. BK, Rowlett RD. Pressure, serotonin and histamine effects on lung multiple-indicator curves in sheep. J Appl Physiol 1978;44:245-53.
42. Kloner RA, Ganote CE, Jennings RB. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974;54:1496-508.
43. Gavin JB, Thomson RW, Humphrey SM, Herdson PB. Changes in vascular morphology associated with the no-reflow phenomenon in ischaemic myo-cardium. Virchows Arch A 1983;399:325-32.
44. Saeed M, Wendland MF, Sakuma H, et al. Coronary artery stenosis: detection with contrast-enhanced MR imaging in dogs. Radiology 1995;196:79-84.
45. Wendland MF, Saeed M, Masui T, Derugin N, Moseley ME, Higgins CB. Echo-planar MR imaging of normal and ischemic myocardium with gadodiamide injection. Radiology 1993;186:535-42.
46. Wilke N, Simm C, Zhang J, et al. Contrast-enhanced first pass myocardial perfusion imaging: correlation between myocardial blood flow in dogs at rest and during hyperemia. Magn Reson Med 1993;29:485-97.
47. Diesbourg LD, Prato FS, Wisenberg G, et al. Quantification of myocardial blood flow and extracellular volumes using a bolus injection of Gd-DTPA: kinetic modeling in canine ischemic disease. Magn Reson Med 1992;23:239-53.